Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02655224
Brief Title: A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids

First Submitted : January 12, 2016
First Submitted that Met QC Criteria : January 12, 2016
First Posted : January 13, 2016 (Estimate)

Results First Submitted : May 16, 2018
Results First Submitted that Met QC Criteria : December 25, 2018
Results First Posted : March 22, 2019

Last Update Submitted that Met QC Criteria : December 25, 2018
Last Update Posted : March 22, 2019